| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $200K | -41.5% |
| Cost of Revenue | $43K | -38.6% |
| R&D Expense | $14.0M | -30.1% |
| SG&A Expense | $9.2M | -30.6% |
| Operating Income | -$23.1M | +30.2% |
| Interest Expense | $2.7M | -34.0% |
| Pre-tax Income | -$26.2M | +33.6% |
| Income Tax | $0 | — |
| Net Income | -$26.2M | +33.6% |
| EPS (Basic) | -$2.65 | +53.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.2M | -57.3% |
| Accounts Receivable | $0 | -100.0% |
| Inventory | $37K | -45.6% |
| Current Assets | $9.0M | -44.4% |
| Total Assets | $18.1M | -33.7% |
| Current Liabilities | $10.8M | +4.7% |
| Long-term Debt | $17.8M | — |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.5M | +13.0% |
| Capital Expenditures | $39K | +160.0% |
| Investing Cash Flow | -$39K | -100.6% |
| Financing Cash Flow | $11.5M | +853.3% |
| Free Cash Flow | -$18.6M | +12.9% |
| $35.7M |
| -1.3% |
| Stockholders' Equity | -$17.6M | -98.6% |